National Reference Centre for Invasive Pneumococcal Diseases, Regional Authority of Public Health Banská Bystrica

Size: px
Start display at page:

Download "National Reference Centre for Invasive Pneumococcal Diseases, Regional Authority of Public Health Banská Bystrica"

Transcription

1 Surveillance of Streptococcus pneumoniae. Current situation in Slovakia. Klement C., 1 Maďarová L., 1 Bottková E., 1 Hupková H., 2 Piačková V., 2 Avdičová M. 1 1 National Reference Centre for Invasive Pneumococcal Diseases, Regional Authority of Public Health Banská Bystrica 2 Institute of Microbiology, Faculty of Medicine, Comenius University, Bratislava

2 National Reference Centre for Invasive Pneumococcal Diseases the NRC has been established since 1 st january 2011 as the result of efforts of many public health and university experts established in Regional Authority of Public Health (RAPH) (RAPH) operates under Ministry of Health of Slovak Republic head of NRC: Assoc. Prof. Cyril Klement MD., PhD. (NMFP ECDC) employees: 6 great cooperation with Institute of Microbiology of Faculty of Medicine, Comenius University

3 Main tasks and objectives of NRC diagnostics of S. pneumoniae isolated from invasive pneumococcal diseases serotyping collection and storage of pneumococcal strains collecting of epidemiological data related to the vaccination introduction of new diagnostic procedures publications and education

4 Diagnostic procedures Commonly used laboratory methods of proof Culture (gold standard) PCR (conventional) Serotyping (Quellung reaction- in cooperation with Institute of Microbiology of Faculty of Medicine, Comenius University) mesacc.edu New diagnostic procedures in the validation process PFGE (after culture) Serotyping using the multiplex PCR (according to the Brito et al. 2003, Pai et al. 2006, Carvahlo et al. 2010, Pimenta et al. 2009)

5 Vaccination in Slovakia since valent conjugate vaccine was approved in Slovakia since 1 st january 2009 part of the routine infant immunization (firstly 7PCV; today 13PCV, 10PCV ); m.; m.; m. in the after approval the 13-valent conjugate vaccine replaced the 7PCV 23-valent pneumococcal polysaccharide vaccine (PPSV 23) mainly recommended for all adults aged 65 years nursing-medicine.blogspot.com

6 Results of Laboratory Diagnostics, 2011 during the strains isolated from severe invasive pneumococcal infections, delivered to NRC for further diagnostics (serotyping, PCR, PFGE) Examined clinical materials, % Blood culture Examined samples according to age groups, % 64% Cerebrospinal fluid Others (BAL; punctates) 49% 29% 22% Children under 2 years Adults aged 65 years Other age groups

7 Serotype Distribution, 2011 Serotype Distribution of S. pneumoniae Isolated from Invasive Diseases, Výskyt sérotypov S. pneumoniae v SR z invazívnych ochorení za rok 2011 Slovak Republic, Number of cases A 6B 14 19F 19C 4 15A 15B 15C 18C 18F 35B 6A 9L Sérotyp Serotype

8 EPIS all confirmed cases (case deffinition) of invasive pneumococcal diseases have to be reported in the SK- Epidemiological Information System (SK- EPIS) total number of reported cases is available on the website

9 Antibiotic Susceptibility Testing development of resistant strains respectively antibiotic susceptibility is monitored by NRC for monitoring resistance of microorganisms to antibiotics Slovak National Antimicrobial Resistance System (

10 To consider the progress that has made with the commitments from the 4 th Pneumo Surveillance Workshop During The Fourth Pneumo Surveillance Workshop, Slovakia made these commitment statements to address throughout 2011: Meeting objectives: 1. The technical guidelines of Ministry of Health for diagnosis and surveillance of invasive pneumococcal disease was developed (approved and valid since 1 st september 2011). 2. We have actively participated in some conferences and published several papers on this issue; introducing of new diagnostic methods (PFGE, multiplex PCR for serotyping).

11 Results & Conclusions very short period (1 year) of NRC activity it is not yet possible to make statistical analysis of obtained data is necessary to strengthen the system for reporting individual cases to Epidemiological Information System (EPIS) effectiveness of transmission of isolated strains (from invasive pneumococcal disease) in to NRC for further typing and analysis Autor: Shutterstock

12 Many thanks for your patience

Annual Epidemiological Report

Annual Epidemiological Report August 2018 Annual Epidemiological Report Key Facts Streptococcus 1Pneumoniae (invasive) in Ireland, 2017 In 2017, 415 confirmed cases of invasive pneumococcal diseases (IPD) were reported in Ireland,

More information

CUMULATIVE INVASIVE PNEUMOCOCCAL DISEASE CASE NUMBERS REPORTED BY THE GERMS-SA SURVEILLANCE PROGRAMME, 2005 TO DATE

CUMULATIVE INVASIVE PNEUMOCOCCAL DISEASE CASE NUMBERS REPORTED BY THE GERMS-SA SURVEILLANCE PROGRAMME, 2005 TO DATE CUMULATIVE INVASIVE PNEUMOCOCCAL DISEASE CASE NUMBERS REPORTED BY THE GERMS-SA SURVEILLANCE PROGRAMME, 5 TO DATE GERMS-SA surveillance programme http://www.nicd.ac.za/?page=germs-sa&id=97 National, active,

More information

Report of Typing & Antimicrobial Susceptibilities of Isolates Causing Invasive Pneumococcal Disease in Ireland,

Report of Typing & Antimicrobial Susceptibilities of Isolates Causing Invasive Pneumococcal Disease in Ireland, Report of Typing & Antimicrobial Susceptibilities of Isolates Causing Invasive Pneumococcal Disease in Ireland, 2011-2013 1. Background Streptococcus pneumoniae is a major cause of life-threatening infections

More information

Surveillance of invasive pneumococcal infection in Belgium

Surveillance of invasive pneumococcal infection in Belgium Surveillance of invasive pneumococcal infection in Belgium National Reference Laboratory Start in 198 Laboratory Microbiology UH Leuven (prof. J. Vandepitte) Capsular type determination Antibiotic susceptibility

More information

ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults

ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults ACIP Recommendations for Pneumococcal 13-valent Conjugate and 23-valent Polysaccharide Vaccine Use among Adults National Center for Immunization & Respiratory Diseases Respiratory Diseases Branch ACIP

More information

To view past issues, go to: The New 13-Valent Pneumococcal Conjugate Vaccine (PCV13)

To view past issues, go to:   The New 13-Valent Pneumococcal Conjugate Vaccine (PCV13) From the Texas Department of State Health Services Immunization Branch The goal of the Vaccine Advisory is to disseminate, in a timely manner, practical information related to vaccines, vaccine-preventable

More information

Streptococcus pneumoniae CDC

Streptococcus pneumoniae CDC Streptococcus pneumoniae CDC Pneumococcal Disease Infection caused by the bacteria, Streptococcus pneumoniae» otitis media 20 million office visits (28-55% Strep)» pneumonia 175,000 cases annually» meningitis

More information

Cumulative invasive pneumococcal disease case numbers reported by the GERMS-SA surveillance programme, 1 January 2012 to 30 April 2018

Cumulative invasive pneumococcal disease case numbers reported by the GERMS-SA surveillance programme, 1 January 2012 to 30 April 2018 Cumulative invasive pneumococcal disease case numbers reported by the GERMS-SA surveillance programme, 1 January 212 to 3 April 218 GERMS-SA surveillance programme GERMS-SA is a national, active, laboratory-based

More information

Cumulative invasive pneumococcal disease case numbers reported by the GERMS-SA surveillance programme, 1 January 2012 to 31 October 2018

Cumulative invasive pneumococcal disease case numbers reported by the GERMS-SA surveillance programme, 1 January 2012 to 31 October 2018 Cumulative invasive pneumococcal disease case numbers reported by the GERMS-SA surveillance programme, 1 January 212 to 31 October 218 GERMS-SA surveillance programme GERMS-SA is a national, active, laboratory-based

More information

EARSS in Ireland, Results of invasive Streptococcus pneumoniae infection (blood/csf) surveillance

EARSS in Ireland, Results of invasive Streptococcus pneumoniae infection (blood/csf) surveillance EARSS in Ireland, 2007 Results of invasive Streptococcus pneumoniae infection (blood/csf) surveillance Antibiotic codes and abbreviations: CTX, Ciprofloxacin ERY, Erythromycin OXA, Oxacillin TCY, Tetracycline

More information

Invasive Pneumococcal Disease Quarterly Report

Invasive Pneumococcal Disease Quarterly Report Invasive Pneumococcal Disease Quarterly Report April June 2018 Prepared as part of a Ministry of Health contract for scientific services by Liza Lopez Helen Heffernan July 2018 Acknowledgements This report

More information

Why is surveillance important after introducing vaccines?

Why is surveillance important after introducing vaccines? Why is surveillance important after introducing vaccines? Dr Michael Edelstein Immunisation Department, National Infections service Public Health England @epi_michael BSAC Spring conference, 12 th March

More information

Pneumococcal vaccines. Safety & Efficacy. Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh

Pneumococcal vaccines. Safety & Efficacy. Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh Pneumococcal vaccines Safety & Efficacy Prof. Rajesh Kumar, MD PGIMER School of Public Health Chandigarh Disclosure Slide X X I DO NOT have any significant or other financial relationships with industry

More information

Pneumococcal Disease and Pneumococcal Vaccines

Pneumococcal Disease and Pneumococcal Vaccines Pneumococcal Disease and Epidemiology and Prevention of - Preventable Diseases Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at

More information

Pneumococcal Vaccines The Impact Of Conjugate Vaccine

Pneumococcal Vaccines The Impact Of Conjugate Vaccine Pneumococcal Vaccines The Impact Of Conjugate Vaccine 1 / 5 2 / 5 3 / 5 Pneumococcal Vaccines The Impact Of Pneumococcal vaccine. The pneumococcal vaccine protects against serious and potentially fatal

More information

9/12/2018. Pneumococcal Disease and Pneumococcal Vaccines. Streptococcus pneumoniae. Pneumococcal Disease. Adult Track. Gram-positive bacteria

9/12/2018. Pneumococcal Disease and Pneumococcal Vaccines. Streptococcus pneumoniae. Pneumococcal Disease. Adult Track. Gram-positive bacteria Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases Pneumococcal Disease and Pneumococcal Vaccines Adult Track Chapter 17 Photographs and images included

More information

Invasive Pneumococcal Disease Quarterly Report

Invasive Pneumococcal Disease Quarterly Report Invasive Pneumococcal Disease Quarterly Report January March 2018 Prepared as part of a Ministry of Health contract for scientific services by Rebekah Roos Helen Heffernan June 2018 Acknowledgements This

More information

Benefits of the pneumococcal immunisation programme in children in the United Kingdom

Benefits of the pneumococcal immunisation programme in children in the United Kingdom Benefits of the pneumococcal immunisation programme in children in the United Kingdom 2006-2014 Professor Mary P E Slack mpeslack@gmail.com March 2015 Disclosure of interest The presenter has received

More information

Diagnosis of Pneumococcal Disease

Diagnosis of Pneumococcal Disease Diagnosis of Pneumococcal Disease Limitations of Surveillance for Invasive Disease David Murdoch University of Otago, Christchurch New Zealand Key Points We are still reliant on culture-based methods for

More information

Incidence per 100,000

Incidence per 100,000 Streptococcus pneumoniae Surveillance Report 2005 Oregon Active Bacterial Core Surveillance (ABCs) Office of Disease Prevention & Epidemiology Oregon Department of Human Services Updated: March 2007 Background

More information

Serotype Distribution and Antimicrobial Resistance of

Serotype Distribution and Antimicrobial Resistance of BioMed Research International Volume 2016, Article ID 6950482, 7 pages http://dx.doi.org/10.1155/2016/6950482 Research Article Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae

More information

National Institute for Communicable Diseases -- Weekly Surveillance Report --

National Institute for Communicable Diseases -- Weekly Surveillance Report -- Weekly Surveillance Report Week 43, 216 National Institute for Communicable Diseases -- Weekly Surveillance Report -- Page 2 Laboratory-Based Respiratory & Meningeal Disease Surveillance 3 Neisseria meningitidis

More information

2016 Vaccine Preventable Disease Summary

2016 Vaccine Preventable Disease Summary 2016 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared October 2017 2016 Summary of Vaccine Preventable Diseases (VPDs) Reported to Ottawa County

More information

Risk profiles and vaccine uptake in children with invasive pneumococcal disease at a tertiary hospital in Tshwane:

Risk profiles and vaccine uptake in children with invasive pneumococcal disease at a tertiary hospital in Tshwane: Risk profiles and vaccine uptake in children with invasive pneumococcal disease at a tertiary hospital in Tshwane: A retrospective review Xandré Dearden www.up.ac.za IPD: disease spectrum and epidemiology

More information

Vaccines for Primary Care Pneumococcal, Shingles, Pertussis

Vaccines for Primary Care Pneumococcal, Shingles, Pertussis Vaccines for Primary Care Pneumococcal, Shingles, Pertussis Devang Patel, M.D. Assistant Professor Chief of Service, MICU ID Service University of Maryland School of Medicine Pneumococcal Vaccine Pneumococcal

More information

Vaccine Preventable Diseases. Rebecca Ward Utah Department of Health Bureau of Epidemiology October 9, 2013

Vaccine Preventable Diseases. Rebecca Ward Utah Department of Health Bureau of Epidemiology October 9, 2013 Vaccine Preventable Diseases In Utah: 2013 Rebecca Ward Utah Department of Health Bureau of Epidemiology October 9, 2013 VPD Overview H3N2v Influenza Seasonal Influenza Pertussis Haemophilus influenzae

More information

Multi-drug Resistant Serotype 19A Pneumococci in Toronto

Multi-drug Resistant Serotype 19A Pneumococci in Toronto TML Lab Rounds January 17, 2008 Multi-drug Resistant Serotype 19A Pneumococci in Toronto The Role of the Microbiology Lab Susan M. Poutanen, MD, MPH, FRCPC Microbiologist/ID Consultant, TML/MSH Assistant

More information

Splenectomy Vaccine Protocol PIDPIC

Splenectomy Vaccine Protocol PIDPIC Splenectomy Vaccine Protocol PIDPIC 6.24.14 Rationale Spleen clears encapsulated bacteria and infected erythrocytes Serves as one of the largest lymphoid tissues where B cells are educated against encapsulated

More information

Two-in-one: GSK s candidate PHiD-CV dual pathogen vaccine

Two-in-one: GSK s candidate PHiD-CV dual pathogen vaccine Two-in-one: GSK s candidate PHiD-CV dual pathogen vaccine Dr. Bernard Hoet Director, Medical affairs GlaxoSmithKline Biologicals Rixensart, Belgium Istanbul, Feb 13, 2008 PHiD-CV: A novel concept in Bacterial

More information

Appendix B: Provincial Case Definitions for Reportable Diseases

Appendix B: Provincial Case Definitions for Reportable Diseases Infectious Diseases Protocol Appendix B: Provincial Case Definitions for Reportable Diseases Disease: Pneumococcal disease, invasive Revised December 2014 Pneumococcal disease, invasive 1.0 Provincial

More information

Haemophilus influenzae

Haemophilus influenzae Haemophilus influenzae type b Severe bacterial infection, particularly among infants During late 19th century believed to cause influenza Immunology and microbiology clarified in 1930s Haemophilus influenzae

More information

New Mexico Emerging Infections Program (EIP) Data in Use Health Status Indicators

New Mexico Emerging Infections Program (EIP) Data in Use Health Status Indicators New Mexico Emerging Infections Program (EIP) Data in Use Health Status Indicators Chad Smelser, MD Medical Epidemiologist - Active Bacterial Core Surveillance Principal Investigator Objectives Understand

More information

Evelyn A. Kluka, MD FAAP November 30, 2011

Evelyn A. Kluka, MD FAAP November 30, 2011 Evelyn A. Kluka, MD FAAP November 30, 2011 > 80% of children will suffer from at least one episode of AOM by 3 years of age 40% will have > 6 recurrences by age 7 years Most common diagnosis for which

More information

Streptococcus Pneumoniae

Streptococcus Pneumoniae Streptococcus Pneumoniae (Invasive Pneumococcal Disease) DISEASE REPORTABLE WITHIN 24 HOURS OF DIAGNOSIS Per N.J.A.C. 8:57, healthcare providers and administrators shall report by mail or by electronic

More information

Title: Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants

Title: Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants Author's response to reviews Title: Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants Authors: Simon Rueckinger (simon.rueckinger@med.uni-muenchen.de)

More information

Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan

Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan ORIGINAL ARTICLE Changes in the Distribution of Capsular Serotypes of Streptococcus pneumoniae Isolated from Adult Respiratory Specimens in Japan Hisashi Shoji 1, Masayuki Maeda 2, Tetsuro Shirakura 3,

More information

International Journal of Infectious Diseases

International Journal of Infectious Diseases International Journal of Infectious Diseases 14 (2010) e197 e209 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Review

More information

Downloaded from irje.tums.ac.ir at 18:09 IRDT on Friday March 22nd :

Downloaded from irje.tums.ac.ir at 18:09 IRDT on Friday March 22nd : .22-27 :4 2 395 3 2 2 3 657838736 : 083838075 : :. 393 ma.karami@umsha.ac.ir : :.. : 95/04/05 : 95/0/23 :. : 3.. :.. 5 () 2. 64... : 370. 5 500 2008 ().() 393. (PCV) (HibCV).(23) 23/.(4) Shetty 200 94

More information

Invasive pneumococcal disease

Invasive pneumococcal disease SURVEILLANCE REPORT Annual Epidemiological Report for 2016 Invasive pneumococcal disease Key facts In 2016, 21 986 confirmed cases of invasive pneumococcal disease (IPD) were reported in the EU/EEA. The

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE 10.1111/j.1469-0691.2004.00869.x Invasive Streptococcus pneumoniae from Portugal: implications for vaccination and antimicrobial therapy I. Serrano, M. Ramirez, the Portuguese Surveillance

More information

Title: Enhancing state-based surveillance for invasive pneumococcal disease

Title: Enhancing state-based surveillance for invasive pneumococcal disease 09-ID-06 Committee: Infectious Diseases Title: Enhancing state-based surveillance for invasive pneumococcal disease I. tatement of the Problem: Cases of invasive pneumococcal disease among children less

More information

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Last Updated: Version 4.4 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Set: Immunization Set Measure ID#: Measure Information Form Collected For: CMS Voluntary Only The Joint Commission

More information

INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, Helen Heffernan. Julie Morgan. Rosemary Woodhouse. Diana Martin

INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, Helen Heffernan. Julie Morgan. Rosemary Woodhouse. Diana Martin INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, 2009 Helen Heffernan Julie Morgan Rosemary Woodhouse Diana Martin Health Group Institute of Environmental Science and Research Ltd (ESR) Kenepuru Science Centre

More information

INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, 2015

INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, 2015 INVASIVE PNEUMOCOCCAL DISEASE IN NEW ZEALAND, 2015 Prepared as part of a Ministry of Health contract for scientific services by Health Group Institute of Environmental Science and Research Limited June

More information

Full public health impact or. cherry-picking?

Full public health impact or. cherry-picking? Full public health impact or cherry-picking? Arto Palmu, MD, PhD, Research manager, head of Clinical Research Team, Department of Public Health Solutions 10.11.2017 Arto Palmu / RIVM2017 1 Disclosure The

More information

Potential Impact of Conjugate Vaccine on the Incidence of Invasive Pneumococcal Disease among Children in Scotland

Potential Impact of Conjugate Vaccine on the Incidence of Invasive Pneumococcal Disease among Children in Scotland JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2006, p. 1224 1228 Vol. 44, No. 4 0095-1137/06/$08.00 0 doi:10.1128/jcm.44.4.1224 1228.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved.

More information

Impact of vaccination on epidemiology in adults

Impact of vaccination on epidemiology in adults Impact of vaccination on epidemiology in adults Jan Verhaegen 1. Data on prospective study on IPD in Belgium (2009-2011) 2. Evolution of capsular types of invasive isolates from adults after introduction

More information

Carga global de la enfermedad neumocócia

Carga global de la enfermedad neumocócia Carga global de la enfermedad neumocócia Ann R. Thomas, MD MPH Public Health Division Portland, Oregon Caracas, Venezuela, January 2008 Acknowledgements to Adam Cohen, CDC Principales Causas de Muertes

More information

Pneumococcal disease: Global burden, epidemiology, scope for vaccine prevention

Pneumococcal disease: Global burden, epidemiology, scope for vaccine prevention Pneumococcal disease: Global burden, epidemiology, scope for vaccine prevention Stephanie Schrag Centers for Disease Control and Prevention Atlanta, GA San Jose, Costa Rica, August 2007 Pneumococcal Carriage

More information

Carga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA

Carga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA Carga global de la enfermedad neumocócia Adam L. Cohen, MD MPH Centers for Disease Control and Prevention Atlanta, GA Santiago, Chile, December 2007 Pneumococcal Carriage and Disease Ear infections Meningitis

More information

Invasive Bacterial Disease

Invasive Bacterial Disease Invasive Bacterial Disease All Streptococcus pneumoniae Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program : 304-558-5358 or 800-423-1271

More information

Additional files. English version of questionnaire, April 3, 2014

Additional files. English version of questionnaire, April 3, 2014 Additional files English version of questionnaire, April 3, 2014 Individual questionnaire You are invited to participate in a survey of parents. This survey is sponsored by the Shanghai Centers for Disease

More information

Towards the Achievement of GHSA 2024 s Overarching Targets

Towards the Achievement of GHSA 2024 s Overarching Targets 정보화파트업무계획 [GHSA] Immunization Towards the Achievement of GHSA 2024 s Overarching Targets 2016년추진업무및 2017년업무계획 ( 사업관리 ) 7 th November 2018 Korea Centers for Disease Control and Prevention I. Overview Contents

More information

2017 Vaccine Preventable Disease Summary

2017 Vaccine Preventable Disease Summary 2017 Vaccine Preventable Disease Summary Prepared 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata October 2018 2017 Summary of Vaccine Preventable Diseases in Ottawa County This is a detailed

More information

Recommendations for Using Pneumococcal Vaccines among Adults

Recommendations for Using Pneumococcal Vaccines among Adults Recommendations for Using Pneumococcal Vaccines among Adults AI Collaborative Webinar July 2017 Tamara Pilishvili Respiratory Diseases Branch, CDC National Center for Immunization & Respiratory Diseases

More information

2015 Vaccine Preventable Disease Summary

2015 Vaccine Preventable Disease Summary 2015 Vaccine Preventable Disease Summary 12251 James Street Holland, MI 49424 www.miottawa.org/healthdata Prepared April 2016 2015 Summary of Vaccine Preventable Diseases (VPD) Reported to Ottawa County

More information

Target Product Profile and Technical Requirements for Conjugated Pneumococcal Vaccines. AMC Pre-tender meeting. Copenhagen 10 March 2011

Target Product Profile and Technical Requirements for Conjugated Pneumococcal Vaccines. AMC Pre-tender meeting. Copenhagen 10 March 2011 Target Product Profile and Technical Requirements for Conjugated Pneumococcal Vaccines 1 Target Product Profile for AMC support The specifications relate to the public health impact and suitability of

More information

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS 2017-2021 A Draft ANGELINA C. SIJAONA THE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERLY AND CHILDREN

More information

Immunization Update: Pneumonia Vaccines

Immunization Update: Pneumonia Vaccines Immunization Update: Pneumonia Vaccines Barbara Resnick, PhD, CRNP, FAAN University of Maryland *Barbara Resnick has no disclosures/no conflicts of interest What Do We Know? An estimated 40,000 to 50,000

More information

WHO posi)on paper on pneumococcal vaccines. Geneva, Switzerland Published in the Weekly Epidemiological Record on 6 Apr 2012

WHO posi)on paper on pneumococcal vaccines. Geneva, Switzerland Published in the Weekly Epidemiological Record on 6 Apr 2012 WHO posi)on paper on pneumococcal vaccines Geneva, Switzerland Published in the Weekly Epidemiological Record on 6 Apr 2012 WHO posi)on paper on pneumococcal vaccines, April 2012 The current posi)on paper

More information

Measure #111 (NQF 0043): Pneumonia Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health

Measure #111 (NQF 0043): Pneumonia Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health Measure #111 (NQF 0043): Pneumonia Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION:

More information

Review Article Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials

Review Article Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials International Journal of Otolaryngology Volume 2012, Article ID 312935, 15 pages doi:10.1155/2012/312935 Review Article Pneumococcal Conjugate Vaccines and Otitis Media: An Appraisal of the Clinical Trials

More information

2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle

2013 Adult Immunization Update. David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle 2013 Adult Immunization Update David H. Spach, MD Professor of Medicine Division of Infectious Diseases University of Washington, Seattle Adult Immunization Update Pertussis Vaccine Influenza Vaccine Zoster

More information

Measure #111 (NQF 0043): Pneumococcal Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health

Measure #111 (NQF 0043): Pneumococcal Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health Measure #111 (NQF 0043): Pneumococcal Vaccination Status for Older Adults National Quality Strategy Domain: Community/Population Health 2017 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY MEASURE TYPE: Process

More information

BCG vaccine and tuberculosis

BCG vaccine and tuberculosis PART 2: Vaccination for special risk groups 2.1 Vaccination for Aboriginal and Torres Strait Islander people Aboriginal and Torres Strait Islander people historically had a very high burden of infectious

More information

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD)

Alberta Health and Wellness Public Health Notifiable Disease Management Guidelines August Pneumococcal Disease, Invasive (IPD) August 2011 Pneumococcal Disease, Invasive (IPD) Revision Dates Case Definition Reporting Requirements Remainder of the Guideline (i.e., Etiology to References sections inclusive) Case Definition August

More information

Risk and Prevention of Pneumococcal Disease in Adults

Risk and Prevention of Pneumococcal Disease in Adults Risk and Prevention of Pneumococcal Disease in Adults Athena 2015. International Conference Antoni Torres. University of Barcelona 1 Pneumococcal pneumonia represents the majority of pneumococcal disease*

More information

PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID

PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID PNEUMONIA : PROMISE FULFILLED? Regina Berba MD FPSMID Objectives of Lecture Know the quality of current evidence based guidelines on immunization Appreciate the performance of pneumonia vaccines in terns

More information

Recommendations for Using Pneumococcal Vaccines among Adults

Recommendations for Using Pneumococcal Vaccines among Adults Recommendations for Using Pneumococcal Vaccines among Adults AI Collaborative Webinar February 2016 Tamara Pilishvili Respiratory Diseases Branch, CDC National Center for Immunization & Respiratory Diseases

More information

Pneumococcal vaccines

Pneumococcal vaccines Pneumococcal vaccines Marco Aurélio Sáfadi, MD, PhD FCM da Santa Casa de São Paulo Challenges in establishing the baseline burden of disease, before implementing a vaccination program S. pneumoniae disease

More information

Polysaccharide and conjugate vaccine responses

Polysaccharide and conjugate vaccine responses Hyporesponsiveness Kim Mulholland Murdoch Childrens Research Institute, Melbourne London School of Hygiene and Tropical Medicine, UK University of Melbourne, Australia Hyporesponsiveness Reduced or absent

More information

Les 2 articles qui peuvent changer votre pratique sur: Vaccination et biothérapies

Les 2 articles qui peuvent changer votre pratique sur: Vaccination et biothérapies Les 2 articles qui peuvent changer votre pratique sur: Vaccination et biothérapies VZV Epidemiology and Pathogenesis 98% adults Respiratory spread 1,000,000/year and increasing CMI continuously boosted

More information

Executive Summary SAGE October 2017, Pneumococcal Conjugate Vaccine Session

Executive Summary SAGE October 2017, Pneumococcal Conjugate Vaccine Session 1 Executive Summary SAGE October 2017, Pneumococcal Conjugate Vaccine Session 1.0 Introduction Currently, WHO has recommended the use of either a 10-valent or 13-valent pneumococcal conjugate vaccine (PCV10

More information

Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia

Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia Capsular Serotype and Antibiotic Resistance of Streptococcus pneumoniae Isolates in Malaysia Cheng-Foh Le 1, Navindra Kumari Palanisamy 2, Mohd Yasim Mohd Yusof 1, Shamala Devi Sekaran 1 * 1 Department

More information

IID&GHTP. Pneumococcal vaccine Africa décembre By: Julie Lajoie

IID&GHTP. Pneumococcal vaccine Africa décembre By: Julie Lajoie IID&GHTP Pneumococcal vaccine Africa décembre 2011 By: Julie Lajoie General information Ecology and Epidemiology of invasive pneumococcal disease (IPD) in sub Saharan Africa is different from that seen

More information

Streptococcus pneumoniae

Streptococcus pneumoniae Streptococcus pneumoniae EPIDEMIOLOGY AND PREVENTION 2^4. November 2007 Prof. Dr. Kathrin Mühlemann Klinik und Poliklinik für Infektionskrankheiten Universität Bern, INSELSPITAL S. pneumoniae: epidemiology

More information

Monitoring results: goals, strategic objectives and indicators

Monitoring results: goals, strategic objectives and indicators page 108 Monitoring results: goals, strategic objectives and indicators 6. SURVEILLANCE Strategic Objective 4: strong immunization sytems are an integral part of a well-functioning health system. Indicator

More information

The Role of the Pharmacist in Pneumococcal Vaccination

The Role of the Pharmacist in Pneumococcal Vaccination The Role of the Pharmacist in Pneumococcal Vaccination The Role of the Pharmacist in Pneumococcal Vaccination Miranda Wilhelm, PharmD Clinical Associate Professor Department of Pharmacy Practice Southern

More information

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013

Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 Narrative report of HIV Preventive programmes in the Slovak Republic as of 31-st December 2013 1. Introduction HIV/AIDS pandemic is a human, social and economic disaster, with far-reaching implications

More information

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections

Pneumococcal vaccination in UK: an update. Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Pneumococcal vaccination in UK: an update Dr Richard Pebody Immunisation Department Health Protection Agency Centre for Infections Leading infectious causes of mortality, 2000 WHO estimates 3.5 Deaths

More information

Invasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland

Invasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland Invasive meningococal diseasefocus on Meningococcal B - epidemiology, international and Ireland Dr Suzanne Cotter, Health Protection Surveillance Centre (HPSC) Scope presentation Meningococccal disease

More information

Evaluating Awareness of Pneumococcal Vaccination Among Adults 65 Years Old and Above Attending a SingHealth Polyclinic A Community Health Study

Evaluating Awareness of Pneumococcal Vaccination Among Adults 65 Years Old and Above Attending a SingHealth Polyclinic A Community Health Study Evaluating Awareness of Pneumococcal Vaccination Among Adults 65 Years Old and Above Attending a SingHealth Polyclinic A Community Health Study Goh Zhaojing and Suriya Prakaash SingHealth Family Medicine

More information

Serotyping pneumococcal meningitis cases in the African meningitis belt using multiplex. PCR on cerebrospinal fluid

Serotyping pneumococcal meningitis cases in the African meningitis belt using multiplex. PCR on cerebrospinal fluid JCM Accepts, published online ahead of print on 9 December 2009 J. Clin. Microbiol. doi:10.1128/jcm.01402-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All

More information

Invasive Pneumococcal Isolates from Danish Infants (0-90 Days) during the Years 1943 to 2013

Invasive Pneumococcal Isolates from Danish Infants (0-90 Days) during the Years 1943 to 2013 Invasive Pneumococcal Isolates from Danish Infants (0-90 Days) during the Years 1943 to 2013 Hans-Christian Slotved*, Tine Dalby, Steen Hoffmann Neisseria and Streptococcus Reference Laboratory (NSRlab),

More information

Adult Immunization Update 2015

Adult Immunization Update 2015 Adult Immunization Update 2015 Objectives Upon completion of this session, the pharmacist should be able to: Compare and contrast previous versions of the ACIP immunization schedules with the most recent

More information

the benefits and potential side effects of pneumococcal immunization; and

the benefits and potential side effects of pneumococcal immunization; and F883 483.80(d) Influenza and pneumococcal immunizations 483.80(d)(1) Influenza. The facility must develop policies and procedures to ensure that- (i) Before offering the influenza immunization, each resident

More information

NEWS RELEASE FOR INFORMATION CONTACT: Tel [203] Tel [203]

NEWS RELEASE FOR INFORMATION CONTACT: Tel [203] Tel [203] NEWS RELEASE FOR INFORMATION CONTACT: Caroline Calderone Baisley Deborah C. Travers Director of Health Director of Family Health Tel [203] 622-7836 Tel [203] 622-3782 September 18, 2017 For Immediate Release

More information

NORTHEAST HOSPITAL CORPORATION

NORTHEAST HOSPITAL CORPORATION NORTHEAST HOSPITAL CORPORATION Title: Influenza and Pneumococcal Immunization Date Effective: 11/04 Date Revised: 7/08, 2/6/12, 3/15/13; 9/13/13 Date Reviewed: Joint Commission Chapter: Provision of Care,

More information

Vaccines, Not Just for Babies

Vaccines, Not Just for Babies Vaccines, Not Just for Babies Meg Fisher, MD Medical Director Disclosures I have no relevant financial relationships with the manufacturers of any commercial products or commercial services discussed in

More information

Immunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012

Immunization Update: New CDC Recommendations. Blaise L. Congeni M.D. 2012 Immunization Update: New CDC Recommendations Blaise L. Congeni M.D. 2012 Polysaccharide Vaccines Vaccine Hib capsule polysaccharide PRP (polyribose ribitol phosphate) Not protective in infants

More information

Vaccine Efficacy IPD and Pneumonia

Vaccine Efficacy IPD and Pneumonia Vaccine Efficacy IPD and Pneumonia Hanna Nohynek, MD PhD National Public Health Institute Helsinki, Finland for 3rd Regional Pneumococcal Symposium Istanbul, Turkey February 13-14, 2008 Vaccine efficacy

More information

EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002

EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 EPIREVIEW INVASIVE PNEUMOCOCCAL DISEASE, NSW, 2002 Robyn Gilmour Communicable Diseases Branch NSW Department of Health BACKGROUND Infection with the bacterium Streptococcus pneumoniae is a major cause

More information

Key words: community-acquired pneumonia, Streptococcus pneumoniae, adults, Poland, CAP incidence Pneumonol Alergol Pol 2016; 84:

Key words: community-acquired pneumonia, Streptococcus pneumoniae, adults, Poland, CAP incidence Pneumonol Alergol Pol 2016; 84: ORIGINAL RESEARCH Rafal Harat 1, Ronika Alexander 2, Sharon Gray 2, Elane M. Gutterman 3, Justyna Pluta 4, Michael Pride 5, Sebastian Shite 5, Joanna Fijolek 1, Jolanta Kozub 1 1 Chrzanów County Hospital,

More information

Superior Immune Response to Protein-conjugate vs. Free Pneumococcal. Polysaccharide Vaccine in COPD. for the COPD Clinical Research Network

Superior Immune Response to Protein-conjugate vs. Free Pneumococcal. Polysaccharide Vaccine in COPD. for the COPD Clinical Research Network Page 32 of 37 Superior Immune Response to Protein-conjugate vs. Free Pneumococcal Polysaccharide Vaccine in COPD Mark T. Dransfield 1, Moon H. Nahm 1, MeiLan K. Han 2, Sarah Harnden 3, Gerard J. Criner

More information

Emerging Infectious Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015

Emerging Infectious Diseases in the Arctic. Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 Emerging Infectious Diseases in the Arctic Tom Hennessy, MD, MPH Arctic Investigations Program October 2, 2015 1 Emerging Infections Outline The emergence of emerging infectious diseases Factors leading

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Management of meningitis and meningococcal disease in children and young people in primary and secondary care. 1.1 Short title

More information

Impact of Universal Infant Immunization with Pneumococcal (Streptococcus pneumonia) Conjugate Vaccines in Alaska

Impact of Universal Infant Immunization with Pneumococcal (Streptococcus pneumonia) Conjugate Vaccines in Alaska Pacific University CommonKnowledge School of Physician Assistant Studies Theses, Dissertations and Capstone Projects 8-2008 Impact of Universal Infant Immunization with Pneumococcal (Streptococcus pneumonia)

More information

"Non-invasive Pneumococcal Diseases dynamics & the Host Age" Roman Prymula Ministry of Health, the Czech Republic

Non-invasive Pneumococcal Diseases dynamics & the Host Age Roman Prymula Ministry of Health, the Czech Republic "Non-invasive Pneumococcal Diseases dynamics & the Host Age" Roman Prymula Ministry of Health, the Czech Republic Disease Caused by S. pneumoniae S. pneumoniae Eustachian Tube Nasopharynx Pharynx Nasal

More information

Pneumococcal Vaccine Introductions Dr. Carsten Mantel WHO/FCH/IVB/EPI

Pneumococcal Vaccine Introductions Dr. Carsten Mantel WHO/FCH/IVB/EPI Pneumococcal Vaccine Introductions 2012 Dr. Carsten Mantel WHO/FCH/IVB/EPI Pneumonia is leading cause of death in children < 5 yrs * Pneumococcus and Hib are the two leading causes of life-threatening

More information